# US 2024/0002913 A1 · Systems and methods for multiplexed analyte detection using antibody-oligonucleotide conjugates

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2024/0002913 A1
- Document ID: US20240002913A1
- Status: Published application
- Kind: A1
- Application number: 18/362,451
- Filed: 2023-07-31
- Published: 2024-01-04
- Earliest claimed: 2018-02-05
- Assignees: G1 Sciences, LLC
- Applicants: G1 Sciences, LLC
- Inventors: Sudha Haran
- Web page: https://patentgrep.com/patent/US20240002913A1

## CPC

- C12Q 1/6837: using probe arrays or probe chips (C12Q1/6874 takes precedence)
- C12Q 1/005: {involving specific analytes or enzymes (including groups of enzymes, e.g. oxydases; C12Q1/004 takes precedence)}
- C12Q 1/6804: Nucleic acid analysis using immunogens (immunoassay G01N33/53)
- C12Q 1/6851: Quantitative amplification
- C12Q 1/6853: using modified primers or templates
- C12Q 1/686: Polymerase chain reaction [PCR]
- C12Q 1/6874: involving nucleic acid arrays, e.g. sequencing by hybridisation
- G01N 33/54306: {Solid-phase reaction mechanisms}
- C12Q 2565/537: characterised by the capture oligonucleotide acting as a primer
- G01N 2458/10: Oligonucleotides as tagging agents for labelling antibodies
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)

## Abstract

Provided herein, in some embodiments, are systems, methods, compositions, and kits for detecting and quantifying analytes using a primary analyte binding molecule conjugated to a nucleic acid template.

## Claims

### Claim 1

A method of measuring the amount of analyte in a sample comprising the steps of
a) Contacting a sample comprising at least one analyte with at least one primary analyte binding molecule; wherein the primary analyte binding molecule is immobilized on a solid support; wherein the analyte binds to the at least one primary analyte binding molecule;
b) Contacting at least one secondary analyte binding molecule with the at least one analyte,
wherein the 5′ end of at least one nucleic acid template is conjugated to the at least one secondary analyte binding molecule; and
wherein the at least one nucleic acid template comprises an oligonucleotide sequence at the 3′ end that hybridizes to a primer; wherein the primer is immobilized at the 5′ end on the solid support adjacent to each of the at least one primary analyte binding molecules;
c) Hybridizing the oligonucleotide sequence to the primer;
d) Performing one or more nucleic acid amplification reactions on the at least one nucleic acid template, so that nucleic acid colonies are generated;
e) Measuring the presence of the nucleic acid colonies to determine the amount of the specified analyte in a sample.

### Claim at position 2

-19. (canceled)

### Claim 20

A kit for measuring the amount of analyte in a sample comprising:
a) at least one primary analyte binding molecule configured to be immobilized on a solid support;
b) at least one primer configured to be immobilized on the solid support; and
c) at least one secondary analyte binding molecule;
wherein the 5′ end of at least one nucleic acid template is conjugated to the at least one secondary analyte binding molecule;
wherein the at least one nucleic acid template comprises an oligonucleotide sequence at the 3′ end that hybridizes to the at least one primer;
wherein the solid support is a flow cell with at least one peak region and one valley region, wherein the primary analyte binding molecule is bound to the valley region of the flow cell, and wherein the primer is bound at a higher position than said primary analyte binding molecule on the flow cell.

### Claim 21 (depends on 20)

The kit of claim 20, wherein the primary analyte binding molecule is selected from the group consisting of: antibodies, antibody fragments, Fab fragments, Fab′ fragments, F(ab′)2 fragments, scFv proteins, analyte specific trapping agents, and nanoparticles.

### Claim 22 (depends on 20)

The kit of claim 20, wherein the secondary analyte binding molecule is selected from the group consisting of: antibodies, antibody fragments, Fab fragments, Fab′ fragments, F(ab′)2 fragments, scFv proteins, analyte specific trapping agents, and nanoparticles.

### Claim at position 6

23 -27. (canceled)

### Claim 28 (depends on 20)

The kit of claim 20, wherein the primer is modified to reduce enzymatic digestion.

### Claim 29 (depends on 29)

The kit of claim 29, wherein the modification is selected from the group consisting of: modifications of the phosphodiester backbone, modifications to the sugar ring, 3′ capping with inverted thymidine, and modifications on the nucleotide bases.

### Claim 30 (depends on 20)

The kit of claim 20, wherein the nucleic acid template sequence is modified to reduce enzymatic digestion.

### Claim 31 (depends on 30)

The kit of claim 30, wherein the modification is selected from the group consisting of: modifications of phosphodiester backbone, modifications to the sugar ring, 3′ capping with inverted thymidine, and modifications on the nucleotide bases.

### Claim 32 (depends on 20)

The kit of claim 20, wherein the nucleic acid sequence template at its 5′ end further comprises an oligonucleotide sequence that is identical to the primer sequence.

### Claim 33 (depends on 20)

The kit of claim 20, wherein the nucleic acid template sequence is the reverse mirror image of its complementary sequence.

### Claim 34 (depends on 20)

The kit of claim 20, wherein the wherein said wherein the 5′ end of a filler is attached to the secondary analyte binding molecule and the 3′ end of said filler is attached to the 5′ end of the nucleic acid template sequence.

### Claim 35 (depends on 34)

The kit of claim 34, wherein said filler sequence is double-stranded.

### Claim 36 (depends on 20)

The kit of claim 20, wherein the amount of analyte in a sample is determined by the presence of a unique recognition sequence associated with a particular analyte binding molecule.

### Claim 37 (depends on 24)

The kit of claim 24, wherein the amount of analyte in a sample is determined by the presence of the nucleic acid colonies in a specific region of the flow cell.

### Claim 38 (depends on 20)

The kit of claim 20, where the presence of the nucleic acid colonies is measured using DNA sequencing methods.

### Claim 39

A system for measuring the amount of analyte in a sample, the system comprising:
a) a source unit configured to house
a sample comprising a least one analyte, the sample configured to contact at least one primary analyte binding molecule, and
at least one secondary analyte binding molecule, wherein the 5′ end of at least one nucleic acid template is conjugated to the at least one secondary analyte binding molecule, and wherein the at least one nucleic acid template comprises an oligonucleotide sequence at the 3′ end;
b) a reaction unit configured to receive
a solid support configured to include (1) at least one primer immobilized on the solid support at the primer 5′ end and (2) the at least one primary analyte binding molecule immobilized on the solid support;
the sample comprising the at least one analyte from the source unit, the at least one analyte configured to bind to the at least one primary analyte binding molecule, and
the at least one secondary analyte binding molecule from the source unit, the at least one secondary analyte binding molecule configured to bind to the at least one analyte, wherein the oligonucleotide sequence at the 3′ end of the nucleic acid template hybridizes to the primer;
wherein the solid support is a flow cell with at least one peak region and one valley region, wherein the primary analyte binding molecule is bound to the valley region of the flow cell, and wherein the primer is bound at a higher position than said primary analyte binding molecule on the flow cell;
c) an amplification unit configured to perform one or more nucleic acid amplification reactions on the at least one nucleic acid template, so that a nucleic acid colony is generated; and
d) an identification unit configured to identify the specific nucleic acid colony associated with the specific analyte to determine the amount of analyte in a sample.

### Claim at position 19

-43. (canceled)

### Claim 44 (depends on 40)

The system of claim 40, wherein the at least one primer is bound to the peak region.

### Claim 45 (depends on 40)

The system of claim 40, wherein the amount of analyte in a sample is determined by the presence of the nucleic acid colonies in a specific region of the flow cell.

### Claim 46

(canceled)

### Claim 47 (depends on 39)

The system of claim 39, comprising a measuring unit that comprises a sequencing unit configured to determine the presence of the nucleic acid colonies using DNA sequencing.

### Claim 48 (depends on 39)

The system of claim 39, wherein the identification unit is configured to identify each specific nucleic acid colony from a plurality of nucleic acid colonies, each nucleic acid colony associated with a specific analyte, to determine the amount of each analyte present.
